Febuxostat acquires the 13th exclusive sale product right
‘Febuxostat,’ which has been prohibited to sell due to the lawsuit winning of generic companies, was registered as the 13th exclusive sales pharmaceutical product.
The Ministry of Food and Drug Safety(MFDS) announced approval of ‘Febuxostat Film 40~80mg’ as exclusive sales pharmaceutical product...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
